China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the efficacy and mechanism of Sanqi Danshen tablets in the treatment of patients with acute myocardial infarction after PCI surgery'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135529
Registration Time: 2026/10/30
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Kunming Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=290217
Published by HT Digital Content Services with permission from Health Daily Digest....